Boehringer/Zealand Dual Agonist Achieves Promising Level Of Weight Loss – Scrip – Informa

The partners’ dual GLP-1/GCGR agonist has achieved up to 14.9% weight loss in obese and overweight adults in a mid-stage trial but rival products …